Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

VU10010

Copy Product Info
😃Good
Catalog No. T23513Cas No. 633283-39-3
Alias VU 10010

VU10010 (VU 10010) is allosteric potentiator of M4 acetylcholine receptors.

VU10010

VU10010

Copy Product Info
😃Good
Purity: 99.36%
Catalog No. T23513Alias VU 10010Cas No. 633283-39-3
VU10010 (VU 10010) is allosteric potentiator of M4 acetylcholine receptors.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$30In StockIn Stock
5 mg$48In StockIn Stock
10 mg$77In StockIn Stock
25 mg$158In StockIn Stock
50 mg$250In StockIn Stock
100 mg$368In StockIn Stock
200 mg$517-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.36%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

VU10010 AI Summary
VU10010 exhibits allosteric activation of the rat recombinant muscarinic M4 receptor, enhancing acetylcholine-induced calcium mobilization, increasing acetylcholine EC50 for calcium mobilization induction, and decreasing acetylcholine Ki for displacement of [3H]NMS from the active binding site. Additionally, it stimulates [35S]GTPgammaS binding and modulates postsynaptic currents in hippocampal pyramidal neurons in rat and mouse models. This compound also demonstrates antiviral activity by inhibiting SARS-CoV-2-induced cytotoxicity in Caco-2 and VERO-6 cells with varying inhibition rates, as well as 19.52% inhibition of SARS-CoV-2 3CL-Pro protease activity at 20 µM. Furthermore, VU10010 shows inhibitory activity against human HDAC6, with 16.5% inhibition using a commercial peptide substrate and 2.55% using a custom peptide substrate..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
VU10010 (VU 10010) is allosteric potentiator of M4 acetylcholine receptors.
SynonymsVU 10010
Chemical Properties
Molecular Weight345.85
FormulaC17H16ClN3OS
Cas No.633283-39-3
SmilesCc1cc(C)c2c(N)c(sc2n1)C(=O)NCc1ccc(Cl)cc1
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 50 mg/mL (144.57 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.78 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.8914 mL14.4571 mL28.9143 mL144.5713 mL
5 mM0.5783 mL2.8914 mL5.7829 mL28.9143 mL
10 mM0.2891 mL1.4457 mL2.8914 mL14.4571 mL
20 mM0.1446 mL0.7229 mL1.4457 mL7.2286 mL
50 mM0.0578 mL0.2891 mL0.5783 mL2.8914 mL
100 mM0.0289 mL0.1446 mL0.2891 mL1.4457 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy VU10010 | purchase VU10010 | VU10010 cost | order VU10010 | VU10010 chemical structure | VU10010 formula | VU10010 molecular weight